Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Sudip Bose Topics Key Points: Losing weight can increase the risk of muscle and bone density loss, whether a person takes a GLP-1 weight loss medication, crash diets or has weight-loss surgery
The efficacy of semaglutide in promoting weight loss underscores its potential as a meaningful component of obesity management strategies, catering especially to those who have struggled with other weight loss methods
(Both medications are also approved to reduce cardiovascular risk in people with known heart disease and either type 2 diabetes or obesity.) Semaglutide belongs to a category of prescription medications known as GLP-1s
Injection sites should be rotated systematically across the abdomen, thighs, and upper arms to prevent lipohypertrophy and ensure consistent absorption
Conclusion This proof-of-concept analysis indicates that semaglutide has the potential to reduce the risk of stroke in people with T2D when prescribed in clinical practice
It's important to inject on the same day each week
